Logo.jpg
AnPac Bio-Medical Science Announces Signing of US$5.2 Million of Definitive Investment Agreements
25 janv. 2023 08h30 HE | ANPAC BIO-MEDICAL SCIENCE CO., LTD.
New York, NY, Jan. 25, 2023 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (the “Company”) (Nasdaq: ANPC), a biotechnology company with operations in the United States and China focused on...
Logo.jpg
AnPac Bio-Medical Sciences Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request A Hearing
20 janv. 2023 16h30 HE | ANPAC BIO-MEDICAL SCIENCE CO., LTD.
New York, NY, Jan. 20, 2023 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (the “Company”) (Nasdaq: ANPC), a biotechnology company with operations in the United States and China focused on...
Logo.jpg
ProPhase Labs to Present at The ThinkEquity Conference
18 oct. 2022 08h00 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, Oct. 18, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be...
Logo.jpg
Nebula Genomics Strengthens Advisory Board with Appointment of Russ Altman, M.D., Ph.D.
17 oct. 2022 08h00 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, Oct. 17, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth-oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly...
Straits Research Pvt Ltd
Chemiluminescence Immunoassay Market Size is projected to reach USD 12.73 Billion by 2030, growing at a CAGR of 7.5%: Straits Research
07 sept. 2022 12h50 HE | Straits Research
New York, United States, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Chemiluminescence immunoassay (CLIA) is an immunological technique used for the detection and monitoring of chronic disorders. The...
Logo.jpg
ProPhase Labs to Present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Conference
03 févr. 2022 08h30 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, Feb. 03, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at...
Logo.jpg
ProPhase Labs to Present at Two Upcoming August Conferences
16 août 2021 08h30 HE | ProPhase Labs, Inc.
GARDEN CITY, NY, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, today announced that Chairman and CEO Ted Karkus is scheduled to...
Logo.jpg
ProPhase Labs to Host Second Quarter 2021 Financial Results Conference Call on Friday, August 13, 2021 at 11:00 a.m. Eastern Time
09 août 2021 08h30 HE | ProPhase Labs, Inc.
GARDEN CITY, NY , Aug. 09, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, will hold a conference call on Friday, August 13, 2021...
Fuisz Pharma Announces Receipt of a Notice of Patent Allowance for Breath Diagnostics; The Invention addresses the Issue of Ambient Contaminants that Skew Results
22 juin 2021 08h00 HE | FUISZ LLC
Franklin, TN, June 22, 2021 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC (Fuisz Pharma) today announced its receipt from the United States Patent and Trademark Office (PTO) of a notice of allowance for App....
Logo.jpg
ProPhase Labs to Present at the Virtual Fall Investor Summit on Monday, November 16, 2020 at 2:30 p.m. Eastern Time
10 nov. 2020 08h30 HE | ProPhase Labs, Inc.
DOYLESTOWN, PA , Nov. 10, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase Labs”), a diversified medical science and technology company, today announced that management will...